Navigation Links
Best Drug for SARS

German investigators believe they have found a potential new drug that might be more effective in the treatment of severe acute respiratory syndrome (SARS) than drugs now being used against the deadly disease. In a research letter published in this week’s issue of The Lancet, the scientists outline results of a study comparing the standard drug used in SARS patients, ribavirin, with four additional antiviral drugs: 6-azauridine, pyrazofurin, mycophenolic acid, and glycyrrhizin. All were tested against two isolates of the SARS virus taken from SARS patients //being treated at Frankfurt University.

The study showed glycyrrhizin, which is used to treat some HIV and hepatitis C infections, was most effective in inhibiting replication of the SARS virus. Ribavirin and mycophenolic acid, by contrast, did not affect replication of the virus, and 6-azauridine and pyrazofurin inhibited replication, but less effectively than glycyrrhizin. Researchers aren’t sure how the drug does the job, but suspect it may be related to its effect on the increased synthesis of nitric oxide, which is known to inhibit replication of several viruses.

Investigators say glycyrrhizin should be studied further for a potential role in the treatment of SARS patients. They write, "Of all the compounds, glycyrrhizin was the most active in inhibiting replication of the SARS-associated virus.
'"/>




Page: 1

Related medicine news :

1. Extensive Campaigning To Warn Against Children’s Growing Affinity To Fast Food In Britai
2. Children’s Stress Levels Directly Related To Maternal Job Satisfaction
3. POCKET To Protect Children’s Privac
4. Children’s obesity linked to video game
5. Children’s Health Improves By Swimmin
6. Teething Problems – Fight Sugar For Children’s Dental Healh
7. Older Teenagers Too To be Treated In Children’s Hospital
8. Parents Unaware of their Children’s Knowledge about Household Firearm
9. Research Documents Children’s Exposure to Pesticide
10. Children’s Center to Lead Largest-Ever Study on Kidney Disease in Childre
11. Parental Time Influences Children’s Nutritio
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... June 26, 2017 , ... If the devil is in ... red these days. According to recent estimates, 75 – 80% of the medical ... Some studies point to Electronic Health Records (EHR) with automated features designed to ...
(Date:6/25/2017)... CA (PRWEB) , ... June 24, 2017 , ... Create a feel-good lyric music video ... above footage and sound in the timeline and write in the lyrics to any song. ... flying back out. Each line of the text can be added modularly for optimal control. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... With a heatwave currently bearing down on Northern ... out at the pool. Being swimsuit ready is easy with laser hair removal. , ... again can be a burdensome routine when all you want to do is get out, ...
(Date:6/24/2017)... ... June 24, 2017 , ... Dr. ... 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable routine ... visits to the dentist fit into their patients’ busy lifestyles. Dental365 also gladly ...
(Date:6/23/2017)... ... June 23, 2017 , ... "The Better Care Reconciliation ... significant harm to people with all chronic conditions, including mental illnesses, while increasing ... place the Affordable Care Act (ACA) requirement that insurers cover pre-existing conditions, it ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... two Phase 2 trials of its RSV F protein recombinant ... bearing age have been published in the journal ... been shared in prior scientific conferences). The Company previously announced ... 2014. Novavax is developing the RSV F Vaccine with the ...
(Date:6/5/2017)... -- The Cincinnati location of Diplomat ... DPLO), has been awarded a Top Workplaces 2017 ... are based on an employee survey administered by WorkplaceDynamics, LLC, ... The survey measures several aspects of workplace culture, including alignment, ... ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology: